KFSHRC and University of Birmingham Join Forces to Revolutionize Bladder Cancer Diagnosis in Saudi Arabia
King Faisal Specialist Hospital & Research Centre (KFSHRC) has partnered with the University of Birmingham’s Bladder Cancer Research Centre (BCRC) in a five-year collaboration to enhance bladder cancer diagnostics in Saudi Arabia. By employing a 23-gene panel, this project introduces advanced molecular diagnostics to identify genetic markers linked to bladder cancer, enabling non-invasive testing options. This partnership not only aims to streamline cancer diagnosis for Saudi patients but also bridges Saudi and UK research efforts, fostering shared advancements in genomic diagnostic methods.
​
Beyond diagnostics, this collaboration emphasizes knowledge exchange between the regions, advancing global health initiatives in precision medicine. “This partnership aligns with our goal of enhancing patient care while bridging geographic and technological divides,” said KFSHRC Urology Department chairman Waleed Altaweel. Both institutions aim to establish new standards in accessible, patient-focused cancer care while upholding stringent privacy protections.